About
3D-tumor based CRISPR functional genomics platform
Areas of Focus
Categories
Small Molecule PharmaceuticalGenetics & GenomicsBiotech
Clinical Trials (20)
View allTotal Trials
20
As Lead Sponsor
14
As Collaborator
6
Total Enrollment
8,281
By Phase
PHASE1: 3NA: 10
By Status
UNKNOWN: 7RECRUITING: 5NOT_YET_RECRUITING: 4COMPLETED: 4
Clinical Trials Pipeline20 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
Today
Hover over trial bars to see details
Recent Trials
NCT06919562Collaborator
OPtimal stEnt Deployment stRategy oF Contemporary sTents - Registry to Evaluate Percutaneous Coronary Intervention Using Bioresorbable Scaffolds With Thinner-strut Construction and Guidance by intracOronary Imaging to REduce Scaffold Failure
N/ANot yet recruiting
117 participants
Started: Sep 30, 2025 · Completed: Aug 31, 2030
NCT07050368Lead Sponsor
A Study Assessing Brain Activity, Safety, Tolerability, and Pharmacokinetics Following Multiple Doses of MLS101 (Psilocybin) in Healthy Volunteers
PHASE1Recruiting
20 participants
Started: Jul 28, 2025 · Completed: Feb 28, 2026
NCT06818435Collaborator
Portuguese Registry with Meril Myval THV Series - MyPORTuVal Registry
N/ANot yet recruiting
150 participants
Started: May 31, 2025 · Completed: Nov 30, 2028
NCT06643637Lead Sponsor
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 in Healthy Participants
PHASE1Completed
16 participants
Started: Nov 8, 2024 · Completed: Mar 12, 2025
NCT06917066Collaborator
MYLEAD Spanish Prospective Registry
N/ARecruiting
500 participants
Started: Oct 23, 2024 · Completed: Dec 31, 2026
Locations (1)
Headquarters
Mountain View, CA, United States
Map
Loading map...